DENTSPLY SIRONA (NASDAQ:XRAY) Updates FY 2025 Earnings Guidance

DENTSPLY SIRONA (NASDAQ:XRAY) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 1.600-1.600 for the period, compared to the consensus earnings per share estimate of 1.870. The company issued revenue guidance of $3.6 billion-$3.7 billion, compared to the consensus revenue estimate of $3.7 billion.

Wall Street Analyst Weigh In

Several research firms recently weighed in on XRAY. Needham & Company LLC restated a “hold” rating on shares of DENTSPLY SIRONA in a report on Friday, September 26th. Wall Street Zen cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Saturday, October 18th. Stifel Nicolaus cut their price objective on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Evercore ISI cut their price objective on DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research report on Wednesday, October 8th. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $18.00 price target on shares of DENTSPLY SIRONA in a research report on Wednesday, October 29th. Two investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $17.91.

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock opened at $12.62 on Thursday. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a market capitalization of $2.52 billion, a PE ratio of -2.66, a price-to-earnings-growth ratio of 0.81 and a beta of 1.00. DENTSPLY SIRONA has a one year low of $11.69 and a one year high of $24.86. The business has a 50 day simple moving average of $13.11 and a 200 day simple moving average of $14.51.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping the consensus estimate of $0.50 by $0.02. The business had revenue of $936.00 million for the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.49 EPS. On average, sell-side analysts forecast that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new stake in DENTSPLY SIRONA during the 1st quarter valued at $26,000. Goldman Sachs Group Inc. boosted its position in DENTSPLY SIRONA by 827.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 2,434,925 shares of the medical instruments supplier’s stock valued at $36,378,000 after buying an additional 2,172,343 shares during the last quarter. Empowered Funds LLC boosted its position in DENTSPLY SIRONA by 8.8% in the 1st quarter. Empowered Funds LLC now owns 16,324 shares of the medical instruments supplier’s stock valued at $244,000 after buying an additional 1,320 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its position in DENTSPLY SIRONA by 7.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 593,021 shares of the medical instruments supplier’s stock valued at $8,860,000 after buying an additional 41,579 shares during the last quarter. Finally, Focus Partners Wealth lifted its stake in shares of DENTSPLY SIRONA by 59.1% during the first quarter. Focus Partners Wealth now owns 25,181 shares of the medical instruments supplier’s stock valued at $376,000 after acquiring an additional 9,355 shares during the period. Institutional investors own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.